Avicenna.AI Secures FDA Clearance For Two Healthcare AI Solutions
- Cardio
- 26/03/2024
Avicenna.AI Secures FDA Clearance For Two Healthcare AI Solutions
READ MOREAvicenna.AI Secures FDA Clearance For Two Healthcare AI Solutions
READ MOREA recent investigation featured in the Diabetes Technology & Therapeutics journal explored the use of tirzepatide among overweight/obese adults wit
READ MOREPreliminary research presented at the American Heart Association’s Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions...
READ MOREImage caption: McMaster University's Jonathan Stokes is one of the researchers who developed a new generative AI model which can design new...
READ MOREIn 2023, healthcare organisations nationwide focused on recovering financially after a tough 2022. Hospitals and health systems saw improvemen
READ MOREA groundbreaking study reveals many individuals enduring extreme poverty in low- and middle-income countries (LMICs) face conditions predispos
READ MOREWhen newborns take their first breath, a complex series of physiological adjustments unfold: their lungs inflate, blood vessels expand, and th
READ MOREGilgamesh Pharma Wins $14M Grant to Develop Safer Ibogaine for Opioid Disorder
READ MOREICC 2024: 14th Annual International Congress of Cardiology
READ MOREInternational Conference on Clinical and Experimental Cardiology 2024
READ MORE